Trial
NCT05413915
Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sarit Assouline
Collaborators
Novartis
Condition
Chronic Myeloid Leukemia
Intervention
Asciminib
Why stopped
Insufficient patient accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-29